查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1553651

人工替代物市場規模、佔有率、趨勢分析報告：按產品、按應用、按地區、細分市場預測，2024-2030

Bioprosthetics Market Size, Share & Trends Analysis Report By Product (Allograft, Xenograft), By Application (Cardiovascular, Plastic Surgery & Wound Healing), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

人工替代物市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球人工替代物市場規模預計將達到76億美元，2024年至2030年複合年成長率為4.4%。

與生活方式相關的習慣發生前所未有的轉變，導致心血管疾病的高發病率，加上容易患心臟病和組織損傷的老齡化人口的增加，預計將在預測期內推動人工替代物市場的需求。

基於合成材料的義肢表現出較差的生物相容性、美觀性和強度，這表明顯然需要採用生物義肢。因此，對組織工程自體、同種異體和異種移植產品的需求不斷成長，預計將為市場提供利潤豐厚的成長機會。

該技術整合了球囊血管成形術和冠狀動脈支架等各種設備，以及從心臟外科和介入性心臟病學等醫學領域借鑒的廣泛技術，為經導管瓣膜置換術帶來了革命性的飛躍。此外，擴大採用超音波、血管造影術、MRI 和 CT 等非侵入性影像技術的組合，使外科醫生能夠監測設備和患者的解剖結構，從而無需進行心臟直視手術。

人工替代物市場報告亮點：

  • 預計同種異體移植市場在預測期內將以顯著的複合年成長率成長。它可以縮短手術時間、縮小切口、提高生理可接受性、提供更大的移植物，並且是使用合成移植物進行手術的更安全的替代方案，因為合成移植物在麻醉下併發症的風險較高，因此具有以下相關優勢，例如：
  • 預計整形外科和創傷治療領域在預測期內的應用領域複合年成長率將超過 9.6%。這一巨大佔有率是由於軟組織修復手術（例如疝氣和腹壁重組）的增加。
  • 此外，根據 NCBI 發表的一項研究，病例的日益複雜性人工替代物了在執行上述手術時採用多學科方法的需求，以減少與慢性疾病相關的發病率。
  • 2023年，歐洲主導了整個人工替代物市場。此外，人口趨勢的後續變化，例如頻繁的產品核可、老年人群的增加、生活方式的變化以及與人工替代物解決方案的可用性相關的更高的意識層級，預計將推動該地區的市場成長。
  • 例如，2016 年 4 月，St. Jude Medical, Inc. 宣佈在歐洲推出 Trifecta 手術瓣膜，為需要主動脈置換術的患者提供增強的選擇。此次發布擴大了 St. Jude Medical 在歐洲的現有產品系列。
  • 該行業的一些主要公司包括 Edwards Lifesciences Corporation、St.Jude Medical, Inc.、Sorin Group、CryoLife, Inc.、Braile Biomedica, Inc. 和 Medtronic Plc，預計將推動其業務擴張。並更頻繁地獲得產品認證。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章人工替代物市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 人工替代物市場分析工具
    • 波特的分析
    • PESTEL分析

第 4 章人工替代物市場：依產品分類的估算與趨勢分析

  • 細分儀表板
  • 人工替代物市場：2023 年和 2030 年產品變化分析
  • 同種異體移植
  • 異種移植

第5章人工替代物市場：按應用估算與趨勢分析

  • 細分儀表板
  • 人工替代物市場：2023 年和 2030 年應用變化分析
  • 心血管
  • 整形外科和創傷治療

第6章人工替代物市場：區域估計與趨勢分析

  • 2023 年及 2030 年人工替代物市場佔有率（按地區）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • LeMaitre Vascular, Inc.
    • Braile Biomedica
    • Labcor Laboratorios Ltda
    • Medtronic
    • Rua Life Sciences Plc（Aortech International Plc.）
    • LivaNova PLC（Sorin Group）
    • Organogenesis Inc.
    • Humacyte Global, Inc.
    • Johnson &Johnson（Ethicon, Inc.）
    • Artivion, Inc.（CryoLife, Inc.）
    • Abbott（St. Jude Medical, Inc.）
    • Edwards Lifesciences Corporation.
    • JenaValve
簡介目錄
Product Code: 978-1-68038-980-7

Bioprosthetics Market Growth & Trends:

The global bioprosthetics market size is expected to reach USD 7.6 billion by 2030, registering to grow at a CAGR of 4.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. The unprecedented upward shift in the lifestyle-associated habits leading to the high prevalence of cardiovascular diseases coupled with the increasing geriatric population base,which is highly susceptible to developing cardiac impairments and tissue damage,are presumed to impel the demand for the bioprosthetics market during the forecast period.

Lower biocompatibility, aesthetics, and strength exhibited by the synthetic material-based prosthetics indicate the indisputable requirement for incorporating bioprosthetics; consequentially, the increasing need for the tissue-engineered autologous, allogenic or xenograft products is anticipated to present the market with lucrative growth opportunities.

The growth in the demand for bioprostheses is attributed mainly to technological advancements comprising trans catheter valve fabrication technology, the construction of which involves a multidisciplinary approach, wherein wide-ranging technologies borrowed from varied devices including balloon angioplasty and coronary stents as well as medical disciplines, such as cardiac surgery and interventional cardiology, are merged to introduce a revolutionary quantum leap in the transcatheter valve replacement procedures. Moreover, a combination of the non-invasive imaging techniques, such as, echo cardiography angiography, MRI, and CT, are increasingly being employed, which allows the surgeons to visualize both the device and the anatomy of the patient thus eliminating the need to conduct an open heart surgery.

Bioprosthetics Market Report Highlights:

  • The allograft segment is expected to exhibit growth at a significant CAGR during the forecast period. This is a consequence of the following associated advantages such as reduced surgical time, smaller incisions, greater physiological acceptability, availability of larger grafts, and a safer alternative to procedures that employ synthetic grafts as they pose a high risk of complications under anesthesia
  • The plastic surgery and wound healing segment is anticipated to witness an exponential CAGR of over 9.6% in the application segment over the forecast period. This substantial share can be attributed to the increasing number of soft tissue repair procedures, such as in hernia and abdominal wall reconstruction
  • Additionally, as per a research published by the NCBI, the increase in case complexities drive the need to apply a multidisciplinary approach in performing the above-mentioned procedures, which augments the use of these bioprosthetics meshes to decrease the morbidity associated with chronic impairments
  • In 2023, Europe dominated the overall bioprosthetics market. Moreover, the subsequent changes in the demographic trends, such as the frequent product approvals, increasing geriatric population base, lifestyle-associated changes, and the high awareness levels pertaining to the availability of bioprosthetics solutions are anticipated to drive the market growth in this region
  • For instance, In April 2016, St. Jude Medical, Inc. announced the European launch of Trifecta Surgical Valve to provide enhanced alternatives to patients requiring aortic valve replacements. This launch resulted in the expansion of the existing product portfolio of St. Jude Medical, Inc. in Europe
  • Some leading players in this industry include Edwards Lifesciences Corporation, St.Jude Medical, Inc., Sorin Group, CryoLife, Inc., Braile Biomedica, Inc., and Medtronic Plc; these players are increasingly involved in adopting collaborative strategies and launching frequent product approvals to facilitate business expansion

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioprosthetics Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioprosthetics Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioprosthetics Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioprosthetics Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Allograft
    • 4.3.1. Allograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Xenograft
    • 4.4.1. Xenograft Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Porcine
      • 4.4.2.1. Porcine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Bovine
      • 4.4.3.1. Bovine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioprosthetics Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioprosthetics Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Cardiovascular
    • 5.3.1. Cardiovascular Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Plastic Surgery & Wound Healing
    • 5.4.1. Plastic Surgery & Wound Healing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million

Chapter 6. Bioprosthetics Market: Regional Estimates & Trend Analysis

  • 6.1. Bioprosthetics Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. U.K.
      • 6.3.2.1. U.K. Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Spain Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Korea Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Bioprosthetics Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. LeMaitre Vascular, Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Braile Biomedica
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Labcor Laboratorios Ltda
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Medtronic
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Rua Life Sciences Plc (Aortech International Plc.)
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. LivaNova PLC (Sorin Group)
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Organogenesis Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Humacyte Global, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Johnson & Johnson (Ethicon, Inc.)
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Artivion, Inc. (CryoLife, Inc.)
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Abbott (St. Jude Medical, Inc.)
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives
    • 7.4.12. Edwards Lifesciences Corporation.
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/ Strategic Initiatives
    • 7.4.13. JenaValve
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/ Strategic Initiatives